Your session is about to expire
← Back to Search
Local Anesthetic
Serratus Plane Block (Local Anesthetic) and Intercostal Block (Local Anesthetic) for Video-assisted Thoracoscopic Surgery
N/A
Recruiting
Led By Abhijit Biswas, MD
Research Sponsored by Lawson Health Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age > 18 years
Patients undergoing elective VATS lung resections including wedge resection, segmentectomy, bi-lobectomy, or lobectomy
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days postoperative
Awards & highlights
Study Summary
"This trial is looking at different pain management options for patients undergoing thoracic surgery. Video assisted thoracic surgery (VATS) is a less invasive procedure compared to traditional surgery, and good pain management is
Who is the study for?
This trial is for adults over 18 years old undergoing elective lung surgery (VATS) with varying health statuses (ASA score 1-4), regardless of gender, who can consent to participate. It's not suitable for those unable to give consent or meet the specific surgical and health criteria.Check my eligibility
What is being tested?
The study compares pain management in VATS patients using two methods: a single intercostal block versus an intercostal block combined with continuous local anesthetic infusion via a Serratus Plane Block catheter. The goal is to see if the combination method improves recovery quality scores.See study design
What are the potential side effects?
Potential side effects may include typical reactions to local anesthetics like numbness, weakness, itching, or low blood pressure. Serious complications are rare but could involve nerve damage or infection at the injection site.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am older than 18 years.
Select...
I am scheduled for a specific type of lung surgery.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ until patient discharge, on average one week.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~until patient discharge, on average one week.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Quality of Recovery
Secondary outcome measures
Hospital readmission
Postoperative complications after thoracic surgery
Postoperative pain scores
+2 moreTrial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Serratus Plane Block (Local Anesthetic) and Intercostal Block (Local Anesthetic)Experimental Treatment1 Intervention
Patients randomized to this group will receive the intercostal block with local anesthetic and the serratus plane block with local anesthetic. Local anesthetic administered will be ropivacaine 0.2%.
Group II: Serratus Plane Block (Placebo) and Intercostal Block (Local Anesthestic)Placebo Group1 Intervention
Patients randomized to this group will receive the intercostal block with local anesthetic and the serratus plane block with saline placebo. Local anesthetic administered will be ropivacaine 0.2%.
Find a Location
Who is running the clinical trial?
Lawson Health Research InstituteLead Sponsor
659 Previous Clinical Trials
413,532 Total Patients Enrolled
Abhijit Biswas, MDPrincipal InvestigatorWestern University, Canada
1 Previous Clinical Trials
120 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are new patients currently being accepted for enrollment in this medical study?
"As per the information available on clinicaltrials.gov, this ongoing trial is actively pursuing eligible participants. The trial was made public on June 30th, 2022 and its most recent update was recorded on February 26th, 2024."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger